Atrium Therapeutics, Inc. Common Stock RNA
$7.67
-1.92%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-10-08 | View → |
| 4 | 4 | 2026-09-22 | View → |
| 4 | 4 | 2026-09-22 | View → |
| 4 | 4 | 2026-09-22 | View → |
| 4 | 4 | 2026-09-22 | View → |
| 4 | 4 | 2026-09-22 | View → |
| 4 | 4 | 2026-09-22 | View → |
| 4 | 4 | 2026-09-22 | View → |
| 4 | 4 | 2026-09-22 | View → |
| 10-Q | 10-Q | 2026-08-13 | View → |
| 8-K | 8-K | 2026-08-13 | View → |
| 8-K | 8-K | 2026-07-14 | View → |
| 10-Q | 10-Q | 2026-05-14 | View → |
| 8-K | 8-K | 2026-05-14 | View → |
| 4 | 4 | 2026-04-22 | View → |
| 4 | 4 | 2026-04-22 | View → |
| 4 | 4 | 2026-04-22 | View → |
| 4 | 4 | 2026-04-22 | View → |
| 4 | 4 | 2026-04-22 | View → |
| 4 | 4 | 2026-04-22 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 4 | 4 | 2026-03-02 | View → |
| 8-K | 8-K | 2026-02-27 | View → |
| 8-K | 8-K | 2026-02-26 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $7.67
- Market Cap
- $133.77 million
- 52-Week Range
- $7.54 – $73.06
- Average Volume
- 394K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.